All In Biotech

Free tool

FAERS Monitor: Timolol Maleate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020963 or its brand name (Timolol Maleate, Timolol Maleate). Reports on generic versions are filed under their own applications.

Reports

7,784

Serious

3,677

47% of reports

Hospitalization

1,550

Death reported

439

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure983
  • drug ineffective579
  • eye pain441
  • fatigue410
  • eye irritation362
  • dizziness291
  • diarrhoea284
  • vision blurred268
  • nausea260
  • off label use260
  • headache245
  • ocular hyperaemia233
  • intraocular pressure increased232
  • dyspnoea229
  • death226

Reports by year received

View as table
YearReports
2004158
2005193
2006156
2007142
2008136
2009133
2010202
2011219
2012309
2013108
2014132
2015252
2016294
2017364
2018367
2019399
20201,435
2021409
2022438
2023514
2024516
2025558
2026349

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,375 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intraocular pressure increasedSignal23249.943.910,883
treatment failureSignal98332.430.629,678
eye painSignal44121.319.48,459
eye irritationSignal36217.115.55,450
ocular hyperaemiaSignal23313.311.72,637
vision blurredSignal2685.34.7930
dizziness2911.61.462
fatigue4101.41.353
diarrhoea2841.21.19
drug ineffective5791.21.118
dyspnoea2291.11.02
headache2451.10.91
nausea2600.90.84
off label use2600.80.713
death2260.70.628

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.